UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Thrombospondin-1 Antagonist of Transforming Growth Factor-β Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II

The American journal of pathology, 2007-09, Vol.171 (3), p.777-789

2007

Volltextzugriff (PDF)

Thrombospondin 1 mediates angiotensin II induction of TGF-β activation by cardiac and renal cells under both high and low glucose conditions

Biochemical and biophysical research communications, 2006-01, Vol.339 (2), p.633-641

2006

Volltextzugriff (PDF)

Effects of early perturbation of the renin–angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats

Vascular pharmacology, 2005-02, Vol.42 (3), p.93-98

2005

Volltextzugriff (PDF)

Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion

Purinergic signalling, 2008-12, Vol.4 (4), p.393-405

2008

Volltextzugriff (PDF)

Antihypertensive drugs with anti-inflammatory properties are more effective in treating postmenopausal hypertensive women

Current hypertension reports, 2009-06, Vol.11 (3), p.162-163

Berecek, Kathleen H.

2009

Volltextzugriff (PDF)

Mammalian Target of Rapamycin: MasTOR Mediator of Cellular Changes in Pathological States?

Hypertension (Dallas, Tex. 1979), 2009-12, Vol.54 (6), p.1221-1222

2009

Volltextzugriff (PDF)

Increased PI3-Kinase in Presympathetic Brain Areas of the Spontaneously Hypertensive Rat

Circulation Research, 2005-02, Vol.96 (3), p.277-279

2005

Volltextzugriff (PDF)

Erratum to “Effects of early perturbation of the renin–angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats” [Vascular Pharmacology 42 (2005) 93–98]

Vascular pharmacology, 2007-11, Vol.47 (5), p.328-328

2007

Volltextzugriff (PDF)

Clinical trials report

Current hypertension reports, 2008-06, Vol.10 (3), p.211-212

2008

Volltextzugriff (PDF)

Treating resistant hypertension with spironolactone

Current hypertension reports, 2008-06, Vol.10 (3), p.211-212

2008

Volltextzugriff (PDF)

Interaction between lifetime captopril treatment and NaCl-sensitive hypertension in spontaneously hypertensive rats and Wistar–Kyoto rats

Journal of hypertension, 1999-07, Vol.17 (7), p.983-991

1999

Volltextzugriff (PDF)

Prevention of Genetic Hypertension by Early Treatment of Spontaneously Hypertensive Rats With the Angiotensin Converting Enzyme Inhibitor Captopril

Hypertension (Dallas, Tex. 1979), 1993-08, Vol.22 (2), p.139-146

1993

Volltextzugriff (PDF)

Antihypertensive ffects of drospirenone and 17α-estradiol in hypertensive postmenopausal women

Current hypertension reports, 2007-07, Vol.9 (3), p.209-210

2007

Volltextzugriff (PDF)

Clinical Trials Report

Current hypertension reports, 2005-06, Vol.7 (3), p.204-205

2005

Volltextzugriff (PDF)

Prevention of Renovascular and Cardiac Pathophysiological Changes in Hypertension by Angiotensin II type 1 Receptor Antisense Gene Therapy

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (5), p.2664-2669

1998

Volltextzugriff (PDF)

Prevention of Hypertension and Vascular Changes by Captopril Treatment

Hypertension (Dallas, Tex. 1979), 1991-02, Vol.17 (2), p.141-150

1991

Volltextzugriff (PDF)

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient

Current hypertension reports, 2004-06, Vol.6 (3), p.212-214

2004

Volltextzugriff (PDF)

Adding low-dose spironolactone to multidrug regimens for resistant hypertension

Current hypertension reports, 2004-06, Vol.6 (3), p.211-212

2004

Volltextzugriff (PDF)

Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?

Physiological genomics, 2001-12, Vol.7 (2), p.79-94

2001

Volltextzugriff (PDF)

Clinical trials report

Current hypertension reports, 2004-05, Vol.6 (3), p.211-214

2004

Volltextzugriff (PDF)

Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats

American journal of physiology. Heart and circulatory physiology, 1997-05, Vol.272 (5), p.H2131-H2138

1997

Volltextzugriff (PDF)

Salt-Induced Hypertension in Normotensive Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 1994-06, Vol.23 (6, Part 1), p.791-796

1994

Volltextzugriff (PDF)

Preface: Proceedings of the Council for High Blood Pressure Research, 1993

Hypertension (Dallas, Tex. 1979), 1994-06, Vol.23 (6), p.A12

Berecek, Kathleen H

1994

Volltextzugriff (PDF)

Central Role for Vasopressin in Cardiovascular Regulation and the Pathogenesis of Hypertension

Hypertension (Dallas, Tex. 1979), 1990-09, Vol.16 (3), p.213-224

1990

Volltextzugriff (PDF)

Role of P2XR Channel Purinergic Signaling in Insulin Secretion: Implications in the Treatment of Diabetes

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(81)
Tagungsberichte
(1)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Thrombospondin-1 Antagonist of Transforming Growth Factor-β Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II

Thrombospondin 1 mediates angiotensin II induction of TGF-β activation by cardiac and renal cells under both high and low glucose conditions

Effects of early perturbation of the renin–angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats

Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion

Antihypertensive drugs with anti-inflammatory properties are more effective in treating postmenopausal hypertensive women

Mammalian Target of Rapamycin: MasTOR Mediator of Cellular Changes in Pathological States?

Increased PI3-Kinase in Presympathetic Brain Areas of the Spontaneously Hypertensive Rat

Erratum to “Effects of early perturbation of the renin–angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats” [Vascular Pharmacology 42 (2005) 93–98]

Clinical trials report

Treating resistant hypertension with spironolactone

Interaction between lifetime captopril treatment and NaCl-sensitive hypertension in spontaneously hypertensive rats and Wistar–Kyoto rats

Prevention of Genetic Hypertension by Early Treatment of Spontaneously Hypertensive Rats With the Angiotensin Converting Enzyme Inhibitor Captopril

Antihypertensive ffects of drospirenone and 17α-estradiol in hypertensive postmenopausal women

Clinical Trials Report

Prevention of Renovascular and Cardiac Pathophysiological Changes in Hypertension by Angiotensin II type 1 Receptor Antisense Gene Therapy

Prevention of Hypertension and Vascular Changes by Captopril Treatment

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient

Adding low-dose spironolactone to multidrug regimens for resistant hypertension

Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?

Clinical trials report

Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats

Salt-Induced Hypertension in Normotensive Spontaneously Hypertensive Rats

Preface: Proceedings of the Council for High Blood Pressure Research, 1993

Central Role for Vasopressin in Cardiovascular Regulation and the Pathogenesis of Hypertension

Role of P2XR Channel Purinergic Signaling in Insulin Secretion: Implications in the Treatment of Diabetes

Suchergebnisse filtern